» Articles » PMID: 39654217

Comparison of Chromosomal Microarray and Karyotyping in Prenatal Diagnosis Using 491 Amniotic Fluid Samples

Overview
Specialty General Medicine
Date 2024 Dec 10
PMID 39654217
Authors
Affiliations
Soon will be listed here.
Abstract

This study was aimed to investigate the performance of chromosomal microarray analysis (CMA) in prenatal diagnosis compared with traditional karyotyping analysis. Both CMA and karyotyping analyses were performed to detect the karyotypes in the amniotic fluid of 491 pregnant women who got prenatal diagnosis at the Center of Prenatal Diagnosis of Shangrao (China) during January 2019 to April 2021. After excluding 2 samples in the CMA analysis and 2 samples in the karyotyping analysis which were failed in detection, the remaining 487 amniotic fluid samples were detected. Both CMA and karyotyping analyses identified 22 cases of aneuploidy chromosome abnormalities, including trisomy 21 (10 cases), trisomy 18 (4 cases), sex chromosome abnormality (5 cases), and other chromosome abnormalities (3 cases). In addition, CMA and karyotyping analyses found 8 cases of fetal chromosomal imbalance. Interestingly, abnormal results were detected by CMA analysis in 10 cases whose results were normal by karyotype analysis. Furthermore, 23 cases of copy number variation (CNVs) with variation of unknown clinical significance (VOUS) were detected by CMA, which accounted for 4.68% (23/491) in all cases. However, CMA was not able to accurately identify some complex karyotypes and mixed chimeras, including 2 cases of chimeras, 4 cases of balanced translocations, 4 cases of pericentric inversions, and 8 cases of other chromosome polymorphisms, indicating karyotyping analysis was superior to detect these chromosome abnormalities compared with CMA analysis. CMA was better in detecting the fracture sites, microduplication and microdeletion with definite pathogenicity, and CNVs with VOUS compared with karyotype analysis.

References
1.
Redin C, Brand H, Collins R, Kammin T, Mitchell E, Hodge J . The genomic landscape of balanced cytogenetic abnormalities associated with human congenital anomalies. Nat Genet. 2016; 49(1):36-45. PMC: 5307971. DOI: 10.1038/ng.3720. View

2.
Wou K, Levy B, Wapner R . Chromosomal Microarrays for the Prenatal Detection of Microdeletions and Microduplications. Clin Lab Med. 2016; 36(2):261-76. DOI: 10.1016/j.cll.2016.01.017. View

3.
Weise A, Liehr T . Rapid Prenatal Aneuploidy Screening by Fluorescence In Situ Hybridization (FISH). Methods Mol Biol. 2018; 1885:129-137. DOI: 10.1007/978-1-4939-8889-1_9. View

4.
Hu T, Wang J, Zhang Z, Zhu H, Liu H, Zhang X . [Application of chromosomal microarray analysis in prenatal diagnosis for fetal abnormalities detected by ultrasonography]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2017; 34(3):317-320. DOI: 10.3760/cma.j.issn.1003-9406.2017.03.001. View

5.
Lauer S, Gresham D . An evolving view of copy number variants. Curr Genet. 2019; 65(6):1287-1295. DOI: 10.1007/s00294-019-00980-0. View